Pluta A, Górski A, Nowaczyk M, Modlińska M
Department of Immunology, Transplantation Institute, Warsaw Medical School, Poland.
Hematol Oncol. 1990 May-Jun;8(3):121-4. doi: 10.1002/hon.2900080302.
In contrast to normal B lymphocytes, CLL cells express CD5 antigen believed to be a T cell marker. We have assessed normal and malignant B cell compartments in CLL patients with the aid of two-colour immunofluorescence techniques (CD5-TRITC, DR-FITC). No clear correlation was found between progression of disease and parameters studied. However, there was a tendency for a diminution of normal B cells in advanced stages of disease.
与正常B淋巴细胞不同,慢性淋巴细胞白血病(CLL)细胞表达被认为是T细胞标志物的CD5抗原。我们借助双色免疫荧光技术(CD5-TRITC、DR-FITC)评估了CLL患者的正常和恶性B细胞区室。未发现疾病进展与所研究参数之间存在明显相关性。然而,在疾病晚期存在正常B细胞减少的趋势。